The information provided is not intended to diagnose, treat, cure, or prevent a health problem or disease, and those seeking personal medical advice should consult with a licensed physician
GHK-Cu exhibits minimal side effects, low oral and excellent subcutaneous bioavailability in mice
It works through amylin receptors to slow gastric emptying, suppress post-meal glucagon release, and signal satiety
The products may not sell or the research may show an approach is not viable, but it is understood that there is risk involved
Both drugs are still under investigation
Pharmaceutical companies that manufacture intravenous glutathione have a marketing agenda and pursue dermatologists to administer this drug to such patients